Assays for hepatitis B surface antigen (HBsAg) are the most frequently used tests to detect HBV infection. Vaccination for HBV can produce transiently detectable levels of HBsAg in patients.

The Food and Drug Administration (FDA) has granted Fast Track designation to PBGENE-HBV, an investigational gene editing therapy for adults with chronic hepatitis B.

Spontaneous loss of hepatitis B e antigen (HBeAg) followed by seroconversion to anti-HBe usually coincides with normalization of serum alanine aminotransferase (ALT) levels, reduction in HBV DNA ...

Viral hepatitis was the most common cause of infectious disease mortality worldwide after tuberculosis in 2024, according to ...

As for efficacy, the company said that two out of three trial subjects witnessed a “substantial” decline in Hepatitis B ...

Notably, those who received nivolumab exhibited higher rates of hepatitis B surface antigen (HBsAg) loss compared to other ...

The first-line screening test, which detects the HBV surface antigen, is affordable and accessible in many low-income countries. But the second test, which uses PCR to measure viral load ...

Use the purifier to isolate the hepatitis B antigen produced by the yeast cells. The vaccine, once administered, will stimulate the immune system to attack the antigen (i.e., the protein coat).

Inside the hepatocytes, HBV produces a surplus of viral antigens, including hepatitis B e antigen (HBeAg) and hepatitis B s antigen (HBsAg), which is HBV’s envelope protein. In addition to the ...